Evaluation of cutpoints for phenotypic hypersusceptibility to efavirenz.
Bosch
Ronald J
RJ
Center for Biostatistics in AIDS Research, Harvard School of Public Health, Boston, MA, USA.
Downey
Gerald F
GF
Katzenstein
David A
DA
Hellmann
Nicholas
N
Bacheler
Lee
L
Albrecht
Mary A
MA
D000480:Alkynes; D019380:Anti-HIV Agents / Q000494:pharmacology*; D048588:Benzoxazines; D003521:Cyclopropanes; D024882:Drug Resistance, Viral; D054303:HIV Reverse Transcriptase / Q000037:antagonists & inhibitors; D015497:HIV-1 / Q000187:drug effects*; D006801:Humans; D010078:Oxazines / Q000494:pharmacology*; D016016:Proportional Hazards Models; D018894:Reverse Transcriptase Inhibitors / Q000494:pharmacology
D000480:Alkynes; D019380:Anti-HIV Agents; D048588:Benzoxazines; D003521:Cyclopropanes; D010078:Oxazines; D018894:Reverse Transcriptase Inhibitors; D054303:HIV Reverse Transcriptase; C098320:efavirenz